Clinical-Microbiomics A/S: Financial statements 2024
CVR: 37230634
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Clinical-Microbiomics A/S (CVR 37230634) has filed annual accounts for 2024. In 2024, the company reported a gross profit of EUR 548,000 and a net result of EUR -4,328,000 compared with EUR -1,951,000 the year before. That is a decrease of 69.2% compared with the year before. Equity in the 2024 report amounted to EUR 88,032,000. The solvency ratio was 96%. The company had 106 employees in the financial year.
- Gross Profit
- EUR 548,000
- Profit/Loss
- EUR -4,328,000
- Equity
- EUR 88,032,000
- Total Assets
- EUR 91,711,000
- Employees
- 106
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 548K EUR | -4.3M EUR | 88M EUR | 106 |
| 2023 | - | 1.8M EUR | -2M EUR | 86.3M EUR | 82 |
| 2022 | - | 19M | -6.9M | 119.5M | 32 |
| 2021 | - | 16.8M | -1.7M | 2.8M | 26 |
| 2020 | - | 17M | 816K | -3.3M | 19 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 1, 2024, is registered as an owner of Clinical-Microbiomics A/S with an ownership share of 5%.
As of July 1, 2024, is registered as an owner of Clinical-Microbiomics A/S with an ownership share of 5%.
Clinical-Microbiomics A/S has published its annual report for 2023. Gross profit came to DKK 1,779,000, and the net result was DKK -1,951,000.
About Clinical-Microbiomics A/S
Clinical-Microbiomics A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Clinical-Microbiomics ApS. The management consists of Anders Christian Neto de Sousa Grøn. The board consists of Manoj Nirmal Dadlani (chair), Bruce Harvey Grant, Caroline Popper and Isabelle Valerie de Cremoux. The company's owners include MANJIN ApS, VENDLER ApS and Health For Life Capital II Prima S.C.A. RAIF. The company has 32 employees (2026). In 2025, the company reported a gross profit of EUR 2,831,000 and a net result of EUR -2,586,000 compared with EUR -4,328,000 the year before. Equity in the 2025 report amounted to EUR 85,447,000.